SPAC · Completed
Senti Biosciences Holdings, Inc.
Formerly Dynamics Special Purpose Corp.
Advance gene circuit-engineered, off-the-shelf CAR-NK cell therapies into clinical development (IND submissions beginning 2023), complete a clinical/commercial-scale cGMP manufacturing facility in Alameda, CA, and expand the gene circuit platform across modalities and therapeutic areas through collaborations (Spark Therapeutics, BlueRock Therapeutics) and potential biomanufacturing partnerships.
Listed instruments
Parties and sources
Every figure on this page is read from filings made with the SEC. Read the filings on EDGAR. How these numbers are derived.
Also tracked for this SPAC
The figures above are what the filings state. These are what SPAC Watch derives from them, and they are in the app.
- Risk classification and the disclosure it is drawn from
- Warrant fair value, exercise terms and redemption triggers
- Redemption history — every vote, rate and share count
- Trust runway, working capital and sponsor loans
- Institutional holders and their reported positions
- Directors, officers and the sponsor’s prior SPACs
See what the filings do not say plainly.
Trust runway, redemption history and warrant fair value for Senti Biosciences Holdings, Inc. and every other SPAC on the market.